Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Global Immunoassay Market to Witness Growth at a CAGR of ~8% by 2030 | DelveInsight


The surge in the immunoassay market is mainly from the rising occurrence of persistent conditions like cancer and lifestyle-related ailments such as diabetes mellitus. Notably, the uptick in different types of cancer, including breast and prostate cancer, plays a pivotal role in driving market growth. Additionally, heightened awareness about early disease detection among individuals is further fueling the immunoassay market's expansion throughout the projected period spanning 2024 to 2030.

LAS VEGAS, May 27, 2024 /PRNewswire/ -- DelveInsight's Immunoassay Market Insights report provides the current and forecast market analysis, individual leading immunoassay companies' market shares, challenges, immunoassay market drivers, barriers, trends, and key market immunoassay companies in the market.

DelveInsight Business Research Logo

Key Takeaways from the Immunoassay Market Report

To read more about the latest highlights related to the immunoassay market, get a snapshot of the key highlights entailed in the Global Immunoassay Market Report

Immunoassay Overview

Immunoassay, a cornerstone in medical diagnostics, revolutionizes the detection of various substances within biological samples through the utilization of the immune system's remarkable specificity. This technique harnesses the interaction between antibodies and antigens, enabling the precise identification and quantification of target molecules, such as hormones, proteins, drugs, or infectious agents, in complex biological matrices. Immunoassays encompass a diverse array of methodologies, including enzyme-linked immunosorbent assays (ELISA), radioimmunoassays (RIA), and chemiluminescent immunoassays (CLIA), each offering distinct advantages tailored to specific diagnostic needs. With its sensitivity, specificity, and adaptability, immunoassay has become indispensable in clinical laboratories, pharmaceutical research, environmental monitoring, and beyond, driving advancements in healthcare and scientific discovery.

The versatility of immunoassay extends beyond traditional laboratory settings, finding applications in point-of-care diagnostics, food safety testing, and forensic analysis. Its rapid turnaround time, minimal sample requirements, and ease of automation render immunoassays invaluable tools in screening large populations for diseases, monitoring therapeutic drug levels, and ensuring the safety and quality of consumables. Moreover, ongoing innovations in immunoassay technology continue to enhance its performance characteristics, enabling the detection of ever lower concentrations of analytes with heightened precision. As the demand for accurate, timely, and cost-effective diagnostic solutions persists, immunoassay remains at the forefront, poised to meet the evolving challenges of modern healthcare and scientific inquiry.

Immunoassay Market Insights

In 2023, North America led the Immunoassay market, largely due to prevalent unhealthy lifestyles in the region leading to a significant number of people suffering from lifestyle-related ailments like diabetes and thyroid disorders. Factors such as strong disease awareness, government backing, and a robust product development landscape further bolster this market dominance.

A key driver of the North American immunoassay market is its widespread application in detecting tumor markers indicative of cancer progression. For example, in 2020, the National Cancer Institute reported approximately 1.8 million cancer diagnoses in the United States alone, with specific cancers like prostate, lung, breast, and colorectal being predominant.

Additionally, statistics from the Government of Canada in 2021 reveal cancer as a leading cause of mortality, underlining the pressing need for early disease detection and thus contributing to the immunoassay market's expansion in the region.

Furthermore, the increasing prevalence of chronic conditions such as coronary artery diseases and strokes among the US population is another significant driver. According to the Centers for Disease Control and Prevention, over 18 million adults in the US had coronary artery disease in 2022, with approximately 805,000 experiencing heart attacks annually. These figures underscore the critical role of immunoassay in identifying cardiac markers for diagnosing cardiovascular disorders, thereby fostering immunoassay market growth.

To know more about why North America is leading the market growth in the immunoassay market, get a snapshot of the Immunoassay Market Outlook 

Immunoassay Market Dynamics

The immunoassay market dynamics are continually evolving, driven by advancements in technology, the increasing prevalence of chronic diseases, and the growing demand for accurate diagnostic tools. One of the key factors shaping the immunoassay market is the rising focus on personalized medicine, which necessitates precise and reliable immunoassays for biomarker detection. This trend is fostering the development of innovative immunoassay platforms capable of detecting multiple analytes simultaneously, thereby enabling tailored treatment strategies for patients.

Moreover, the global immunoassay market is influenced by the expanding applications of immunoassays across various sectors, including clinical diagnostics, pharmaceuticals, and biotechnology. As healthcare providers and researchers seek to enhance disease diagnosis and drug development processes, there is a growing demand for high-throughput and sensitive immunoassay techniques. This has led to the emergence of automated immunoassay systems and multiplexing technologies, which offer improved efficiency and cost-effectiveness, driving market growth.

Additionally, factors such as increasing healthcare expenditure, rising awareness about early disease detection, and the adoption of immunoassay-based point-of-care testing are fueling the immunoassay market expansion. Furthermore, the COVID-19 pandemic has underscored the importance of rapid and accurate diagnostic tests, leading to a surge in demand for immunoassays for infectious disease detection. As the healthcare industry continues to prioritize preventive healthcare and precision medicine, the immunoassay market is poised for significant growth and innovation in the coming years.

Get a sneak peek at the immunoassay market dynamics @ Immunoassay Market Dynamics Analysis

Report Metrics

Details

Coverage

Global

Study Period

2021?2030

Immunoassay Market CAGR

~8%

Key Immunoassay Companies

Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, ALPCO, Autobio, PHC Corporation, Trivitorn Healthcare, Werfen, Danaher Corporation, Sysmex Corporation, Awareness Technology Inc, ZECEN Biotech Co., Quidel Corporation, among others

Immunoassay Market Assessment

Which MedTech key players in the immunoassay market are set to emerge as the trendsetter explore @ Immunoassay Companies 

Table of Contents 

1

Report Introduction

2

Executive summary

3

Regulatory and Patent Analysis

4

Key Factors Analysis

5

Porter's Five Forces Analysis

6

Immunoassay Market Layout

7

Global Company Share Analysis ? Key 3-5 Companies

8

Immunoassay Market Company and Product Profiles

9

Project Approach

10

About DelveInsight

Interested in knowing the immunoassay market by 2030? Click to get a snapshot of the Immunoassay Market Trends

Related Reports

Radioimmunoassay Market

Radioimmunoassay Market Insight, Competitive Landscape, and Market Forecast ? 2030 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key radioimmunoassay companies, including DIAsource, MP BIOMEDICALS, Merck KGaA, Tecan Trading AG, Svar Life Science, Institute of Isotopes Co. Ltd., PerkinElmer Inc., Danaher Corporation, among others.

Chemiluminescence Immunoassay Market

Chemiluminescence Immunoassay Market Insight, Competitive Landscape, and Market Forecast ? 2030 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key chemiluminescence immunoassay companies, including Shenzhen Mindray Bio-Medical Electronics Co., Ltd, Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Maccura Biotechnology Co., DiaSorin, Autobio, Diatron, Daan Gene Co., Ltd, Trivitron Healthcare, Werfen, ALPCO, Medcaptain Medical Technology Co., Ltd., ZECEN Biotech Co., Ltd, PHC Holdings Corporation, Awareness Technology, Inc., Rayto Life and Analytical Sciences Co., Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Guangzhou Jinde Biotech Co., Ltd., among others.

ELISA Market

ELISA Market Insight, Competitive Landscape, and Market Forecast ? 2030 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key ELISA companies, including Abbott, F. Hoffmann-La Roche Ltd, Erba Mannheim, Synbiotik, Maccura Biotechnology Co., Ltd., Thermo Fisher Scientific, DiaSorin, PerkinElmer Inc., Diatron, Werfen, ALPCO, Agilent, InBios International Inc., Awareness Technology Inc., Elabscience Biotechnology Inc., J. Mitra & Co. Pvt. Ltd., Rayto Life and Analytical Sciences Co., Ltd., BD, Trivitron Healthcare, among others.

Polymerase Chain Reaction Market

Polymerase Chain Reaction Market Insight, Competitive Landscape, and Market Forecast ? 2030 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key PCR companies, including Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Qiagen, Agilent Technologies Inc., Standard Biotools, F. Hoffmann-La Roche Ltd., Eppendorf, Avance Biosciences Inc., Merck & Co. Inc., Abbott, Promega Corporation, Takara Bio Inc., Endress+Hauser Group Services AG, BioMérieux, GenMark Diagnostics Inc., Grifols SA, Hologic Inc., BD, Sysmex Corporation, Stilla, among others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Contact Us
Shruti Thakur
[email protected]
+14699457679
https://www.delveinsight.com/medical-devices

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

 

SOURCE DelveInsight Business Research, LLP


These press releases may also interest you

at 10:45
Pomerantz LLP announces that a class action lawsuit has been filed against Global Cord Blood Corporation ("Global Cord" or the "Company") and certain officers. The class action, filed in the United States District Court for the Southern District of...

at 10:45
Pomerantz LLP announces that a class action lawsuit has been filed against Gritstone bio, Inc. ("Gritstone" or the "Company") and certain officers. The class action, filed in the United States District Court for the Northern District of California,...

14 jun 2024
Freed-Hardeman University conferred 377 degrees upon a talented group of students during FHU's 154th commencement exercises Saturday, May 11, 2024. In addition to the 274 bachelor's degrees, 11 associate degrees, two education specialist degrees, 81...

14 jun 2024
Today, Flag Day, the American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient organization in the nation, announced an expansion of its successful national, non-partisan voter registration and mobilization...

14 jun 2024
The global governance risk and compliance (GRC) platform market size is estimated to grow by USD 37.63 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 13.64% during the forecast period. Increased need to...

14 jun 2024
Sable Resources Ltd. ("Sable" or the "Company") announces that further to the Company's press release of May 14, 2024 on the entering into of the option agreement to acquire a 100% interest in the Perk-Rocky Project, the Company has received TSX...



News published on and distributed by: